Joseph Horrigan
Hoofd Techniek/Wetenschap/O&O bij AMO Pharma Ltd.
Actieve functies van Joseph Horrigan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - | - |
AMO Pharma Ltd.
 AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Joseph Horrigan
Eerdere bekende functies van Joseph Horrigan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Hoofd Techniek/Wetenschap/O&O | 10-08-2012 | - |
Opleiding van Joseph Horrigan
| Rochester Christian University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Australië | 2 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Health Technology |
- Beurs
- Insiders
- Joseph Horrigan
- Ervaring
